High Risk Breast Cancer Screening Program

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Organisation for Oncology and Translational Research.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Organisation for Oncology and Translational Research
ClinicalTrials.gov Identifier:
NCT00509509
First received: July 29, 2007
Last updated: May 22, 2012
Last verified: May 2012
  Purpose

Objectives:

  • To screen population with high risk for breast cancer
  • To promote the concept and importance of surveillance mammography
  • To find out the incidence of breast cancer in population who are in high risk for breast cancer
  • To collect blood samples for molecular analysis

Condition
Breast Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: High Risk Breast Cancer Screening Program

Resource links provided by NLM:


Further study details as provided by Organisation for Oncology and Translational Research:

  Eligibility

Ages Eligible for Study:   41 Years and older
Genders Eligible for Study:   Female
Sampling Method:   Probability Sample
Study Population

Women aged over 40 with high risk of breast cancer

Criteria

Inclusion Criteria:

  • Female
  • > 40 years of age
  • Women who have first-degree relative suffered from breast cancer
  • Women who have first-degree relative suffered from ovarian cancer
  • Family history of male breast cancer
  • Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40
  • Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members
  • Personal history of ovarian cancer
  • Personal history of premalignant conditions of breast and ovary

Exclusion Criteria:

  • Women with mammogram within one year
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00509509

Contacts
Contact: Louis WC Chow (852)2861 0286 lwcchow@unimed.hk

Locations
Hong Kong
UNIMED Medical Institute Recruiting
Wanchai, Hong Kong
Contact: Louis WC Chow    (852)2861 0286    lwcchow@unimed.hk   
Sponsors and Collaborators
Organisation for Oncology and Translational Research
Investigators
Principal Investigator: Louis WC Chow UNIMED Medical Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00509509     History of Changes
Other Study ID Numbers: OOTR-SBR001
Study First Received: July 29, 2007
Last Updated: May 22, 2012
Health Authority: Hong Kong: Ethics Committee

Keywords provided by Organisation for Oncology and Translational Research:
Hereditary Breast Cancer (BRCA1, BRCA2)

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on July 31, 2014